Search
for
Sort by
Research 781–810 of 1000+
- An Industry-Relevant Metal Mixture, Iron Status, and Reported Attention-Related Behaviors in Italian Adolescents
- The 5alpha-reductase type 1, but not type 2, gene is expressed in anagen hairs plucked from the vertex area of the scalp of hirsute women and normal individuals
- Review of Pippalyadi Agad in Cumulative Toxicity of Cosmetics w.s.r. to Dushivisha
- Alopecia androgenética en varones jóvenes: un indicador clínico temprano de resistencia a la insulina
- MC4R variants rs12970134 and rs17782313 are associated with obese polycystic ovary syndrome patients in the Western region of Saudi Arabia
- Use of Botulinum Toxin for Androgenic Alopecia: A Systematic Review
- Metabolic Syndrome and Skin Diseases
- Dermatologic Manifestations of Polycystic Ovary Syndrome
- Cutaneous manifestations of polycystic ovary syndrome: A cross-sectional clinical study
- Drugs and Androgenetic Alopecia: What to look out for
- Activity of 17β-(N-Alkyl/arylformamido) and 17β-[(N-Alkyl/aryl) alkyl/arylamido]-4-methyl-4-aza-5α-androstan-3-ones as 5α-Reductase Inhibitors in the Hamster Flank Organ and Ear11The research has been supported by Endorecherche that is seeking patent protection for the new compounds. F. Labrie is President of Endorecherche.
- Cyclin-Dependent Kinase 4/6 Inhibitors and Dermatologic Adverse Events: Results from the EADV Task Force “Dermatology for Cancer Patients” International Study
- Thyroid hormone action in epidermal development and homeostasis and its implications in the pathophysiology of the skin
- Erosive Pustular Dermatosis: Delving into Etiopathogenesis and Management
- Expression of Hypothalamic–Pituitary–Thyroid Axis RelatedGenes in the Human Skin
- A Review of the Impact of Calorie Restriction on Stem Cell Potency
- Alopecia Areata: Burden of Disease, Approach to Treatment, and Current Unmet Needs
- Impact of Reporter Type on Signal Detection of Cancer Therapy–Induced Alopecia: A Hypothesis-Generating Study Using the FDA Adverse Event Reporting System
- Pharmacological management of polycystic ovary syndrome
- Biotin and biotinidase deficiency
- Noncalcemic actions of 1,25-dihydroxyvitamin D3 and clinical applications
- [Commentary] The Polyfollicular Anovulatory Androgenic Syndrome: A New Label for an Old Syndrome
- Inhibitors of 5α -Reductase Type I in LNCaP Cells from the Roots of Angelica koreana
- Clinical manifestations of polycystic ovary syndrome
- AN UPDATED OVERVIEW OF POLYCYSTIC OVARY SYNDROME
- Polycystic Ovary Syndrome: A Complex Interplay of Hormones and Metabolism
- Management OF Patients with Polycystic Ovary Syndrom
- Polycystic Ovary Syndrome: Current Insights Into Etiology, Symptoms, And Treatment Options
- Approach to the Patient: Diagnostic Challenges in the Work Up for Polycystic Ovary Syndrome
- THE MULTIFACETED APPROACH TO POLYCYSTIC OVARIAN SYNDROME: A REVIEW OF TRADITIONAL AND ALLOPATHIC MEDICINE